Cholesterol ester transfer protein: A molecule with three faces?

Critical Reviews in Clinical Laboratory Sciences

Volumn 35, Issue 6, 1998, Pages 517-546

  Stevenson, Colin G ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Atherogenesis; Atherosclerosis; Cholestero(y)l ester transfer protein; Cholesterol; Cholesterol esters; Coronary artery disease; Diabetes; Enzymes; Hepatic lipase; High density lipoproteins; Human; Knockout mice; Lecithin cholesteryl acyl transferase; Lipoproteins; Low density lipoproteins; Metabolic processes; Reverse cholesterol transport; Transfer proteins; Transgenic mice; Triglycerides; Very low density lipoproteins

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; LIPID TRANSPORT; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; ASIAN CONTINENTAL ANCESTRY GROUP; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL ESTERS; CORONARY ARTERIOSCLEROSIS; FEMALE; GLYCOPROTEINS; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MALE; MICE; MUTATION; RECEPTORS, LDL; RISK ASSESSMENT;

MUS MUSCULUS;

EID: 0032427623     PISSN: 10408363     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408369891234264     Document Type: Review

References (51)

1. Hegele RA. The pathogenesis of atherosclerosis. Clin Chim Acta 1996; 246: 21-38.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9.
3. Tall AR. Plasma lipid transfer proteins. Annu Rev Biochem 1995; 64: 235-58.
4. Connolly DT, Heuvelman D Glenn K. Inactivation of cholesteryl ester transfer protein by cysteine modification. Biochem Biophys Res Commun 1996; 223:42-7.
5. Agellon LB, Walsh A, Hayek T, et al. Reduced high-density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J Biol Chem 1992; 266: 10796-801.
6. Gaynor BJ, Sand T, Clark RW, et al. Inhibition of cholesteryl ester transfer protein activity in hamsters alters HDL lipid composition. Atherosclerosis 1994; 110: 101-9.
7. Benoist F, Lau P, McDonnell M, et al. Cholesteryl ester transfer protein mediates selective uptake of high density lipoprotein cholesteryl esters by human adipose tissue. J Biol Chem 1997; 272: 23572-7.
8. Kinoshita M, Teramoto T, Shimazu N, et al. CETP is a determinant of serum LDL cholesterol but not HDL cholesterol in healthy Japanese. Atherosclerosis 1996; 120: 75-82.
9. Oliveira HCF, Chouinard RA, Agellon LB, et al. Human cholesteryl ester transfer protein gene proximal promoter contains dietary cholesterol positive responsive elements and mediates expression in small intestine and periphery while predominant liver and spleen expression is controlled by 5x distal sequences. Cis-acting sequences mapped in transgenic mice. J Biol Chem 1996; 271: 31831-8.
10. Tall AR. Plasma cholesteryl ester transfer protein and high-density lipoprotein: new insights from molecular genetic studies. J Intern Med 1995; 237: 5-12.
11. Quinet E, Yang TP, Marinos C, et al. Inhibition of the cellular secretion of cholesteryl ester transfer protein by a variant protein formed by alternative splicing of mRNA. J Biol Chem 1993; 268: 16891-4.
12. Quinet E, Tall A, Ramakrishnan R, et al. Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. J Clin Invest 1991; 87: 1559-66.
13. Marotti KR, Castle CK, Boyle TP, et al. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 1993; 364: 73-75.
14. Jacobs DR, Mebane I, Bangdiwala SI, et al. High-density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Program Prevalence Study. Am J Epidemiol 1990; 131: 32-47.
15. Bhatnagar D, Durrington PN, Channon KM, et al. Increased transfer of cholesteryl esters from high-density lipoproteins to low-density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease. Atherosclerosis 1993; 98: 25-32.
16. Mabuchi H, Yagi K, Haraki T, et al. Molecular genetics of cholesterol transport and cholesterol reverse transport disorders (familial hypercholesterolemia and CETP deficiency) and coronary heart disease. Ann NY Acad Sci 1995; 748: 333-41.
17. Gotoda T, Kinoshita M, Ishibashi S, et al. Skipping of exon 14 and possible instability of both the mRNA and the resultant truncated protein underlie a common cholesteryl ester transfer protein deficiency in Japan. Arterioscler Thromb Vasc Biol 1997; 17: 1376-81.
18. Inazu A, Jiang XC, Haraki T, et al. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest 1994; 94: 1872-82.
19. Tamminen M, Kakko S, Kesaniemi YA, et al. A polymorphic site in the 3x untranslated region of the cholesteryl ester transfer protein (CETP) gene is associated with low CETP activity. Atherosclerosis 1996; 124: 237-47.
20. Sakai N, Santamarina-Fojo S, Yamashita S, et al. Exon 10 skipping caused by intron 10 splice donor site mutation in cholesteryl ester transfer protein gene results in abnormal downstream splice site selection. J Lipid Res 1996; 37: 2065-73.
21. Chiba H, Akita H, Tsuchihashi K, et al. Quantitative and compositional changes in high density lipoprotein subclasses in patients with various genotypes of cholesteryl ester transfer protein deficiency. J Lipid Res 1997; 38: 1204-16.
22. Fruchart JC. Lipoprotein containing apolipoprotein A-I and reverse transport of cholesterol. Ann Pharm Fr 1994; 52: 117-23.
23. Hayek T, Masucci-Magoulas L, Jiang X, et al. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J Clin Invest 1995; 96: 2071-4.
24. Oliveira HC, Ma L, Milne R, et al. Cholesteryl ester transfer protein activity enhances plasma cholesteryl ester formation. Studies in CETP transgenic mice and human genetic CETP deficiency. Arterioscler Thromb Vasc Biol 1997; 17: 1045-52.
25. Stein Y, Stein O, Olivecrona T, et al. Putative role of CETP in removal of cholesteryl ester from vascular interstitium, studied in a model system in cell culture. Biochim Biophys Acta 1985; 834: 336-45.
26. Morton, RE. Interaction of plasma-derived lipid transfer protein with macrophages in culture. J Lipid Res 1988; 29: 1367-77.
27. Hennessy LK, Kunitake ST Kane JP. Apolipoprotein A-I containing lipoproteins, with or without apolipoprotein A-II, as progenitors of pre-beta high-density lipoprotein particles. Biochemistry 1993; 32: 5759-65.
28. Kinoshita M, Arai H, Fukasawa M, et al. Apolipoprotein E enhances lipid exchange between lipoproteins mediated by cholesteryl ester transfer protein. J Lipid Res 1993; 34: 261-8.
29. Von Eckardstein A, Huang Y Assmann G. Role of high density lipoprotein subclasses in reverse cholesterol transport. In: Assmann G, (ed.) HDL deficiency and atherosclerosis. P. 17. Boston: Kluwer Academic Publishers, 1995.
30. Zhong S, Sharp DS, Grove JS, et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 1996; 97: 2917-23.
31. Ritsch A, Drexel H, Amann FW, et al. Deficiency of cholesteryl ester transfer protein. Description of the molecular defect and the dissociation of cholesteryl ester and triglyceride transport in plasma. Arterioscler Thromb Vasc Biol 1997; 17: 3433-41.
32. Breslow JL. Familial disorders of high-density lipoprotein metabolism. In: Scriver CR, Beaudet AL Sly WS, et al. eds. The metabolic and molecular basis of inherited disease. Vol. 2. Pp. 2031-52. New York: McGraw-Hill, Inc., 1995.
33. Sakai N, Yamashita S, Hirano KI, et al. Decreased affinity of low-density lipoprotein (LDL) particles for LDL receptors in patients with cholesteryl ester transfer protein deficiency. Eur J Clin Invest 1995; 25: 332-9.
34. Yamashita S, Ishigami M, Arai T, et al. Very high-density lipoproteins induced by plasma cholesteryl ester transfer protein (CETP) have a potent antiatherogenic function. Ann NY Acad Sci 1995; 748; 606-8.
35. Hirano KJ, Yamashita S, Sakai N, et al. Molecular defect and atherogenicity in cholesteryl ester transfer protein deficiency. Ann NY Acad Sci 1995; 748: 599-602.
36. Zilversmit DB. Atherogenic nature of triglycerides, post-prandial lipemia, and triglyceride-rich remnant lipoproteins. Clin Chem 1995; 41: 153-8.
37. Guerin M, Dolphin PJ Chapman MJ. Cholesteryl ester acceptors among the LDL subspecies of subjects with familial hypercholesterolemia. Arterioscler Thromb 1994; 14: 679-85.
38. Nigon F, Lesnik P, Rouis M, et al. Discrete subspecies of human low-density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J Lipid Res 1991; 32: 1741-54.
39. Lassel TS, Guerin M, Auboiron S, et al. Preferential cholesteryl ester acceptors among triglyceride-rich lipoproteins during alimentary lipemia in normolipidemic subjects. Arterioscler Thromb Vasc Biol 1998; 18: 65-74.
40. Guyton AC. Lipid metabolism. In: Textbook of medical physiology. Pp 754-64. Toronto: W.B. Saunders Company, 1991.
41. Goldberg DM, Hahn SE Parkes JG. Beyond alcohol: beverage consumption and cardiovascular mortality. Clin Chim Acta 1995; 237: 155-87.
42. Song GJ, Han GH Chae JJ. The effects of the cholesterol ester transfer protein gene and environmental factors on the plasma high density lipoprotein cholesterol levels in the Korean population. Mol Cells 1997; 7: 615-9.
43. Hui SP. Frequency and effect on plasma lipoprotein metabolism of a mutation in the cholesteryl ester transfer protein gene in the Chinese. Hokkaido Igaku Zasshi 1997; 72: 319-27.
44. Kuivenhoven JA, Jukema JW, Zwinderman AH, et al. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. N Engl J Med 1998; 338: 86-93.
45. Liinamaa MJ, Hannuksela ML, Kesaniemi YA, et al. Altered transfer of cholesteryl esters and phospholipids in plasma from alcohol abusers. Arterioscler Thromb Vasc Biol 1997; 17: 2940-7.
46. Sugano M, Makino N Yanaga T. Effect of dietary omega-3 eicosapentaenoic acid supplements on cholesteryl ester transfer from HDL in cholesterol-fed rabbits. Biochim Biophys Acta 1997; 1346: 17-24.
47. Arii K, Suehiro T Yamamoto M. Suppression of plasma cholesteryl ester transfer protein activity in acute hyperinsulinemia and effect of plasma nonesterified fatty acid. Metabolism 1997; 46: 1166-70.
48. Bagdade JD, Ritter MC Subbaiah PV. Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus. Eur J Clin Invest 1991; 21: 161-7.
49. Passarelli M, Catanozi S, Nakandakare ER, et al. Plasma lipoproteins from patients with poorly controlled diabetes mellitus and "in vitro" glycation of lipoproteins enhance the transfer rate of cholesteryl ester from HDL to apo B-containing lipoproteins. Diabetologia 1997; 40: 1085-93.
50. Shen GX, Novak C Angel A. Effect of dietary Vitamin E supplementation on cholesteryl ester transfer activity in hamster adipose tissue. Atherosclerosis 1996; 124: 211-9.
51. Foger B, Ritsch A, Doblinger A, et al. Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol: studies in normotriglyceridemia and moderate hypertriglyceridemia. Arterioscler Thromb Vasc Biol 1996; 16: 1430-6.